Literature DB >> 3621457

Poly(I).poly(C), a potential drug carrier for the antitumor agent mitoxantrone: in vitro drug binding study.

H G Eichler, R Mader, B Blöchl-Daum, G Steger, H Rainer.   

Abstract

Coupling of mitoxantrone, a new antitumor agent, to a macromolecular carrier system may improve the drug's selectivity of action and pharmacokinetic properties. We have studied in vitro binding of mitoxantrone to poly(I).poly(C), a macromolecular, double-stranded homoribopolymer, by equilibrium dialysis and high-performance liquid chromatography (HPLC). Results showed high binding affinity for mitoxantrone to poly(I).poly(C) (Kd = 1.05 X 10(-6) M), the calculated number of mitoxantrone-binding sites is 60 per molecule poly(I).poly(C). In view of the good tolerance in clinical studies, poly(I).poly(C) may thus be a useful drug carrier for mitoxantrone. A mitoxantrone:poly(I).poly(C) ratio of 1:30 (w/w) is recommended for therapeutic studies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3621457     DOI: 10.1007/bf00252966

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  5 in total

1.  Chemotherapy through lysosomes with a DNA-daunorubicin complex.

Authors:  A Trouet; D Deprez-de Campeneere; C De Duve
Journal:  Nat New Biol       Date:  1972-09-27

2.  [Increased transfer ribonucleic acid uptake of human leucocytes following gene activation by phytohaemagglutinin and leucemic degeneration (author's transl)].

Authors:  H Rainer; U Ganzinger; P Höcker; E Pittermann; A Stacher; E Deutsch; K Moser
Journal:  Klin Wochenschr       Date:  1974-02-01

3.  Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acids.

Authors:  J Kapuscinski; Z Darzynkiewicz; F Traganos; M R Melamed
Journal:  Biochem Pharmacol       Date:  1981-02-01       Impact factor: 5.858

4.  The pharmacokinetics and metabolism of mitoxantrone in man.

Authors:  G Ehninger; B Proksch; G Heinzel; E Schiller; K H Weible; D L Woodward
Journal:  Invest New Drugs       Date:  1985       Impact factor: 3.850

5.  Experimental antitumor activity of aminoanthraquinones.

Authors:  R K Johnson; R K Zee-Cheng; W W Lee; E M Acton; D W Henry; C C Cheng
Journal:  Cancer Treat Rep       Date:  1979-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.